China Drug Approvals | 2023 | NMPA Drug Approvals | Pharma | Healthcare | China | iPharmaCenterChina's National Medical Products Administration (NMPA) has accepted Astellas Pharma's Xtandi (enzalutamide) New Drug Application (NDA)...
China Drug Approvals | 2022 | NMPA Drug Approvals | Pharma | Healthcare | China | iPharmaCenterTakeda announced that the National Medical Products Administration (NMPA) of China approved Exkivity (mobocertinib) for treating adults...
China Healthcare News | Drug News | iPharmaCenterDecember 23, 2022 Eisai initiated data submission for BLA of lecanemab in China for Alzheimer's Eisai and Biogen announced that they have...